Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: Jul 14, 2023
Date Accepted: Apr 10, 2024

The final, peer-reviewed published version of this preprint can be found here:

Consequences of Data Loss on Clinical Decision-Making in Continuous Glucose Monitoring: Retrospective Cohort Study

Braem CIR, den Braber N, Vollenbroek-Hutten MMR, Hermens HJ, Urgert T, Yavuz US, Veltink PH, Laverman GD

Consequences of Data Loss on Clinical Decision-Making in Continuous Glucose Monitoring: Retrospective Cohort Study

Interact J Med Res 2024;13:e50849

DOI: 10.2196/50849

PMID: 39083801

PMCID: 11325125

Evaluation of Data Loss in Continuous Glucose Monitoring: Consequences on Clinical Decision Making

  • Carlijn Irene Raymond Braem; 
  • Niala den Braber; 
  • Miriam Marie Rosé Vollenbroek-Hutten; 
  • Hermie J. Hermens; 
  • Thomas Urgert; 
  • Utku S. Yavuz; 
  • Peter H. Veltink; 
  • Gozewijn Dirk Laverman

ABSTRACT

Background:

The impact of missing data on individual continuous glucose monitoring (CGM) data is unknown but can influence clinical decision making for patients.

Objective:

Therefore, we aimed to investigate the consequences of data loss on glucose metrics in individual patient recordings of continuous glucose monitors and its effect on clinical decision making.

Methods:

CGM data were collected from patients with type 1 and 2 diabetes using the FreeStyle Libre sensor. We selected 7–28 day periods of 24-hour of continuous data without any missing values from each individual patient. To mimic real-world data loss, missing data ranging from 5–50% was introduced into the dataset. From this modified dataset the clinical metrics time below range (TBR), time below range level 2 (TBR2) and other common glucose metrics were calculated in the data sets without and with data loss. Recordings in which glucose metrics deviated relevantly due to data loss, as determined by clinical experts, were defined as expert panel boundary errors (εEPB). These errors were expressed as a percentage of the total number of recordings.

Results:

A total of 84 patients contributed to 798 recordings over 28 days. With 5–50% data loss for 7–28 days recordings the εEPB varied from 0.0% to 20.0% for TBR and 0.0% to5.4% recordings for TBR2. In the case of 14-day recordings, TBR and TBR2 episodes completely disappeared due to 30% data loss in 0.3% and 6.1% of the cases, respectively. However, the initial values of the disappeared TBR and TBR2 were relatively small (< 0.15%).

Conclusions:

To ensure that missing data has no more than a 5% impact on all glucose metrics, we recommend having a 14-day CGM recording with a maximum of 30% data loss. Clinical Trial: NCT05584293


 Citation

Please cite as:

Braem CIR, den Braber N, Vollenbroek-Hutten MMR, Hermens HJ, Urgert T, Yavuz US, Veltink PH, Laverman GD

Consequences of Data Loss on Clinical Decision-Making in Continuous Glucose Monitoring: Retrospective Cohort Study

Interact J Med Res 2024;13:e50849

DOI: 10.2196/50849

PMID: 39083801

PMCID: 11325125

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.